Old Europe threatened by dragons of the Orient

摘要

The countries which have historically been major producers of active substances such as France,Germany,United Kingdom,United States and Japan are worried.They fear they are now less attractive with the emergence of new producers in China and India.Will the Asians be happy just to produce for their own local or regional market? Or do they plan to flood the European and American markets with different segments of products? What impact will this reshuffling of the cards have on the pharmaceutical market,both directly on levels of primary production and also on the location of secondary production?